Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of MXN 3.08 trillion. The enterprise value is 4.05 trillion.

Market Cap	3.08T
Enterprise Value	4.05T

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Jan 24, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

The trailing PE ratio is 18.38.

PE Ratio	18.38
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.01, with an EV/FCF ratio of 19.74.

EV / Earnings	24.17
EV / Sales	3.10
EV / EBITDA	8.01
EV / EBIT	11.99
EV / FCF	19.74

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.76.

Current Ratio	1.17
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	2.75
Debt / FCF	6.85
Interest Coverage	5.28

Financial Efficiency

Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 6.37%.

Return on Equity (ROE)	9.06%
Return on Assets (ROA)	4.64%
Return on Invested Capital (ROIC)	6.37%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	16.37M
Profits Per Employee	2.07M
Employee Count	88,000
Asset Turnover	0.29
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.43% in the last 52 weeks. The beta is 0.57, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+19.43%
50-Day Moving Average	539.31
200-Day Moving Average	539.01
Relative Strength Index (RSI)	53.22
Average Volume (20 Days)	15,987

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.22

Income Statement

In the last 12 months, Pfizer had revenue of MXN 1.33 trillion and earned 167.35 billion in profits. Earnings per share was 29.42.

Revenue	1.33T
Gross Profit	983.67B
Operating Income	340.23B
Pretax Income	167.18B
Net Income	167.35B
EBITDA	485.97B
EBIT	340.23B
Earnings Per Share (EPS)	29.42

Full Income Statement

Balance Sheet

The company has 426.69 billion in cash and 1.40 trillion in debt, giving a net cash position of -978.13 billion.

Cash & Cash Equivalents	426.69B
Total Debt	1.40T
Net Cash	-978.13B
Net Cash Per Share	n/a
Equity (Book Value)	1.84T
Book Value Per Share	324.32
Working Capital	153.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 265.55 billion and capital expenditures -60.62 billion, giving a free cash flow of 204.94 billion.

Operating Cash Flow	265.55B
Capital Expenditures	-60.62B
Free Cash Flow	204.94B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.19%, with operating and profit margins of 25.66% and 12.62%.

Gross Margin	74.19%
Operating Margin	25.66%
Pretax Margin	12.61%
Profit Margin	12.62%
EBITDA Margin	36.65%
EBIT Margin	25.66%
FCF Margin	15.46%

Dividends & Yields

This stock pays an annual dividend of 31.96, which amounts to a dividend yield of 5.92%.

Dividend Per Share	31.96
Dividend Yield	5.92%
Dividend Growth (YoY)	12.13%
Years of Dividend Growth	1
Payout Ratio	118.44%
Buyback Yield	0.16%
Shareholder Yield	6.08%
Earnings Yield	5.44%
FCF Yield	6.66%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	n/a